Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2534]

AACR: Targeted investigational therapy shows early promise against multiple cancer types

AACR: Targeted investigational therapy shows early promise against multiple cancer types

AACR: Blood-based biomarker may identify prostate cancers that will be resistant to enzalutamide

AACR: Blood-based biomarker may identify prostate cancers that will be resistant to enzalutamide

ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate cancer

ESTRO: Six months hormonal treatment in addition to radiotherapy improves survival for men with localised prostate...

ESTRO: Brachytherapy helps maintain erectile function in prostate cancer patients without compromising treatment outcomes

ESTRO: Brachytherapy helps maintain erectile function in prostate cancer patients without compromising treatment...

ESTRO: New test developed to detect men at high risk of prostate cancer recurrence

ESTRO: New test developed to detect men at high risk of prostate cancer recurrence

Certain genetic variants may put bladder cancer patients at increased risk of cancer recurrence

Certain genetic variants may put bladder cancer patients at increased risk of cancer recurrence

New UK approach to prostate cancer screening needed

New UK approach to prostate cancer screening needed

More intensive radiotherapy is better than less for localised prostate cancer

More intensive radiotherapy is better than less for localised prostate cancer

Genetic screening can identify men with advanced prostate cancer

Genetic screening can identify men with advanced prostate cancer

Study reveals potential route to bladder cancer diagnostics, treatments

Study reveals potential route to bladder cancer diagnostics, treatments

More from ecancer